Phio Pharmaceuticals
PHIO
#10681
Rank
HK$94.74 M
Marketcap
HK$8.16
Share price
-2.80%
Change (1 day)
-59.10%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -HK$85.45 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$68.21 Million a decrease over its 2024 earnings that were of -HK$56.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$85.45 Million25.27%
2025 -HK$68.21 Million21.65%
2024 -HK$56.07 Million-33.96%
2023 -HK$84.9 Million-5.7%
2022 -HK$90.03 Million-13.6%
2021 -HK$0.11 Billion51.09%
2020 -HK$68.97 Million-1.28%
2019 -HK$69.86 Million21.03%
2018 -HK$57.72 Million-53.1%
2017 -HK$0.13 Billion74.49%
2016 -HK$70.54 Million-12.02%
2015 -HK$80.17 Million16.17%
2014 -HK$69.01 Million-57.95%
2013 -HK$0.17 Billion62.45%
2012 -HK$0.11 Billion0.87%
2011 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.8 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA